Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The kidney's role in systemic metabolism-still much to learn.

Literature DB >> 28407131

The kidney's role in systemic metabolism-still much to learn.

Ian H de Boer^1,2,3, Kristina M Utzschneider^3,4.

Abstract

Mesh：

Year: 2017 PMID： 28407131 PMCID： PMC5837666 DOI： 10.1093/ndt/gfx027

Source DB: PubMed Journal: Nephrol Dial Transplant ISSN： 0931-0509 Impact factor: 5.992

× No keyword cloud information.

20 in total

1. Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis.

Authors: Martina Guthoff; Robert Wagner; Dorothea Vosseler; Andreas Peter; Silvio Nadalin; Hans-Ulrich Häring; Andreas Fritsche; Nils Heyne
Journal: Nephrol Dial Transplant Date: 2017-04-01 Impact factor: 5.992

2. Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.

Authors: S M Haffner; M P Stern; R M Watanabe; R N Bergman
Journal: Eur J Clin Invest Date: 1992-03 Impact factor: 4.686

Review 3. Insulin resistance in chronic kidney disease: a systematic review.

Authors: Belinda Spoto; Anna Pisano; Carmine Zoccali
Journal: Am J Physiol Renal Physiol Date: 2016-10-05

4. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors: S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal: Diabetes Date: 1993-11 Impact factor: 9.461

5. Lipoprotein heterogeneity in end-stage renal disease.

Authors: J Joven; E Vilella; S Ahmad; M C Cheung; J D Brunzell
Journal: Kidney Int Date: 1993-02 Impact factor: 10.612

6. Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp.

Authors: Iram Ahmad; Leila R Zelnick; Nicole R Robinson; Adriana M Hung; Bryan Kestenbaum; Kristina M Utzschneider; Steven E Kahn; Ian H de Boer
Journal: Am J Physiol Endocrinol Metab Date: 2017-01-10 Impact factor: 4.310

7. Serum cystatin C and the incidence of type 2 diabetes mellitus.

Authors: K Sahakyan; K E Lee; A Shankar; R Klein
Journal: Diabetologia Date: 2011-03-05 Impact factor: 10.122

8. Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

Authors: Laetitia Koppe; Elsa Nyam; Kevin Vivot; Jocelyn E Manning Fox; Xiao-Qing Dai; Bich N Nguyen; Dominique Trudel; Camille Attané; Valentine S Moullé; Patrick E MacDonald; Julien Ghislain; Vincent Poitout
Journal: J Clin Invest Date: 2016-08-15 Impact factor: 14.808

The kidney's role in systemic metabolism-still much to learn.

1. Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis.

2. Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.

Review 3. Insulin resistance in chronic kidney disease: a systematic review.

4. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

5. Lipoprotein heterogeneity in end-stage renal disease.

6. Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp.

7. Serum cystatin C and the incidence of type 2 diabetes mellitus.

8. Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

9. Physical activity and metabolic health in chronic kidney disease: a cross-sectional study.

10. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

1. Resting metabolic rate and its adjustments as predictors of risk protein-energy wasting in hemodialysis patients.

Review 2. Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction.